Close Menu
World Economist – Global Markets, Finance & Economic Insights
  • Home
  • Economist Impact
    • Economist Intelligence
    • Finance & Economics
  • Business
  • Asia
  • China
  • Europe
  • Economy
  • USA
    • Middle East & Africa
    • Highlights
  • This week
  • World Economy
    • World News
What's Hot

Yuan’s long-term hedge costs equalise for first time since 2011

November 25, 2025

Yuan’s long-term hedge costs equalise for first time since 2011

November 25, 2025

Yuan’s long-term hedge costs equalise for first time since 2011

November 25, 2025
Facebook X (Twitter) Instagram
Tuesday, November 25
Facebook X (Twitter) Instagram
World Economist – Global Markets, Finance & Economic Insights
  • Home
  • Economist Impact
    • Economist Intelligence
    • Finance & Economics
  • Business
  • Asia
  • China
  • Europe
  • Economy
  • USA
    • Middle East & Africa
    • Highlights
  • This week
  • World Economy
    • World News
World Economist – Global Markets, Finance & Economic Insights
Home » PPMA pinpoints key reasons for business closure by top pharma firms – Business & Finance
Economist Intelligence

PPMA pinpoints key reasons for business closure by top pharma firms – Business & Finance

adminBy adminNovember 25, 2025No Comments2 Mins Read
Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
Share
Facebook Twitter Pinterest Email Copy Link
Post Views: 4


ISLAMABAD: Some of the top global pharmaceutical companies have left Pakistan due to a revision of their business plan, rupee depreciation and due to competition with the local pharmaceutical companies.

According to senior representatives of the Pakistan Pharmaceutical Manufacturing Association (PPMA) and officials of the Federal Ministry for National Health Services and Regulations (NHSR) most of these companies have closed down their manufacturing operations in Pakistan as per their revised business plans. They said that these pharmaceutical giants are now focused on high valued select products.

During the past three years five major multinational pharmaceutical companies including Bayer, ICI Pakistan, Sanofi-Aventis, Pfizer, and Novartis stopped their operations in Pakistan. These facilities have been transferred to Pakistani companies to ensure supply of essential medicines remains uninterrupted.

Federal Minister for NHSR, Syed Mustafa Kamal termed the move as a strategic shift by the companies rather than a shutdown of production.

Talking to Business Recorder on the subject, former PPMA Chairman Dr Sheikh Kaiser Waheed said that these companies have not stopped their operations due to multiple reasons as noted above adding that Pakistani pharma industry was performing very well but the market shrank considerably due to the ongoing conflict with Afghanistan.

Local Pharma industry was also facing serious challenges due to increasing costs of production, however the industry is committed to achieving the USD 30 billion five-year export target set, Waheed added.

He further maintained that the target was realistic but only if the government continues its reforms. “While we already produce more than 90 percent of the country’s medicines domestically, the true test ahead is to compete globally with respect to innovation, quality, and trust, not price alone,” he said.

He urged the government to set up an independent trade body to resolve the industry challenges and boost exports. He said that within the past two years the government has brought some industry friendly reforms given that in the past the industry faced significant hurdles in export processes, but now, export registrations are being granted within a week, which is a major step forward.

Copyright Business Recorder, 2025



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
admin
  • Website

Related Posts

Economist Intelligence

SECP approves amendments to PSX Regulations – Business & Finance

November 25, 2025
Economist Intelligence

Formal cooperation between PNSC, BSC proposed – Business & Finance

November 25, 2025
Economist Intelligence

Lifting of ban on gold Import, export hailed – Business & Finance

November 25, 2025
Economist Intelligence

IMF report: FPCCI urges for reforms to curb corruption – Business & Finance

November 25, 2025
Economist Intelligence

PIDE study highlights enormity of power sector crisis – Markets

November 25, 2025
Economist Intelligence

Mashreq Bank introduces ‘first-ever’ profit on current accounts in Pakistan – Business & Finance

November 24, 2025
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

SECP approves amendments to PSX Regulations – Business & Finance

November 25, 2025

Formal cooperation between PNSC, BSC proposed – Business & Finance

November 25, 2025

PPMA pinpoints key reasons for business closure by top pharma firms – Business & Finance

November 25, 2025

Lifting of ban on gold Import, export hailed – Business & Finance

November 25, 2025
Latest Posts

PSX hits all-time high as proposed ‘neutral-to-positive’ budget well-received by investors – Business

June 11, 2025

Sindh govt to allocate funds for EV taxis, scooters in provincial budget: minister – Pakistan

June 11, 2025

US, China reach deal to ease export curbs, keep tariff truce alive – World

June 11, 2025

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Recent Posts

  • Yuan’s long-term hedge costs equalise for first time since 2011
  • Yuan’s long-term hedge costs equalise for first time since 2011
  • Yuan’s long-term hedge costs equalise for first time since 2011
  • EU ministers court Trump on joint China policy, even as public scepticism grows
  • Visitor in Thailand who fed turtle a plastic wristband sought by park officials

Recent Comments

No comments to show.

Welcome to World-Economist.com, your trusted source for in-depth analysis, expert insights, and the latest news on global finance and economics. Our mission is to provide readers with accurate, data-driven reports that shape the understanding of economic trends worldwide.

Latest Posts

Yuan’s long-term hedge costs equalise for first time since 2011

November 25, 2025

Yuan’s long-term hedge costs equalise for first time since 2011

November 25, 2025

Yuan’s long-term hedge costs equalise for first time since 2011

November 25, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Archives

  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • June 2024
  • October 2022
  • March 2022
  • July 2021
  • February 2021
  • January 2021
  • November 2019
  • April 2011
  • January 2011
  • December 2007
  • July 2007

Categories

  • AI & Tech
  • Asia
  • Banking
  • Business
  • Business
  • China
  • Climate
  • Computing
  • Economist Impact
  • Economist Intelligence
  • Economy
  • Editor's Choice
  • Europe
  • Europe
  • Featured
  • Featured Business
  • Featured Climate
  • Featured Health
  • Featured Science & Tech
  • Featured Travel
  • Finance & Economics
  • Health
  • Highlights
  • Markets
  • Middle East
  • Middle East & Africa
  • Middle East News
  • Most Viewed News
  • News Highlights
  • Other News
  • Politics
  • Russia
  • Science
  • Science & Tech
  • Social
  • Space Science
  • Sports
  • Sports Roundup
  • Tech
  • This week
  • Top Featured
  • Travel
  • Trending Posts
  • Ukraine Conflict
  • Uncategorized
  • US Politics
  • USA
  • World
  • World & Politics
  • World Economy
  • World News
© 2025 world-economist. Designed by world-economist.
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.